| TA152 |
Coronary artery disease - drug-eluting stents (TA152) |
|
-
-
Drug-eluting stents for the treatment of coronary artery disease
Drug-eluting stents are recommended as a possible treatment for people with coronary artery disease only if:
- the artery to be treated is less than 3 mm in diameter or the affected section of the artery is longer than 15 mm, and
- the additional cost of the drug-eluting stents over bare-metal stents is £300 or less.
This guidance replaces sections 1.2-1.4 of NICE technology appraisal guidance 71 (2003).
Additional funding information for this guidance can be found on the Department of Health website.
-
Other information
How this guidance was produced
Background information
- Coronary artery disease - drug-eluting stents: review decision - October 2010
- NICE issues guidance on the use of drug-eluting stents for the treatment of coronary artery disease
- TA152 Coronary artery disease - drug-eluting stents: review proposal August 2010
- TA152 Coronary artery disease - drug-eluting stents: appendix A provisional matrix of stakeholders
- TA152 Coronary artery disease - drug-eluting stents: appendix B proposal paper presented to the Institute's Guidance Executive
- Review Decision - July 2009: Appendix 1: Proposal comment summary table
- Review Decision - July 2009
- Review proposal - May 2009
This page was last updated: 07 March 2011
-
Guidance formats
-
Implementation tools and resources
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
